The University of Chicago Header Logo

A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.

A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry. 2009 Apr 01; 65(7):600-6.

View in: PubMed